04/09/2026
FIP used to be a conversation no veterinarian wanted to have.
Today, that’s changed.
With GS-441524, we’re seeing survival rates that were unimaginable just a few years ago — across wet, dry, ocular, and even neurological FIP.
But outcomes don’t just depend on the drug.
They depend on:
• Accurate compounding
• Proper dosing protocols
• Fast turnaround
• Pharmacists who understand FIP
At PetScript, we work closely with clinics to ensure they have reliable access to compounded GS-441524 and Molnupiravir — without delays that can impact outcomes.
Because in FIP cases, time matters.
Learn more here -
GS-441524 has transformed FIP treatment. Here's a clinical overview for veterinarians — dosing protocols, compounded formulations, and what to look for in a compounding pharmacy.